Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry W Grigsby

Showing results (31-40 of 190) with videos related to

Pageof 19
Sort By:
Gynecologic Oncology|November 7, 2009
A new method of anatomically conformal vaginal cuff HDR brachytherapyDouglas A Miller, Susan Richardson, Perry W Grigsby
Cancer|November 23, 2005
FDG-PET in carcinoma of the uterine cervix with endometrial extensionAndrew J Hope, Paban Saha, Perry W Grigsby
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
Tumor volume discrepancies between FDG-PET and MRI for cervical cancerDaniel J Ma, Jian-Ming Zhu, Perry W Grigsby
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Change in T2-fat saturation MRI correlates with outcome in cervical cancer patientsDaniel J Ma, Jian-Ming Zhu, Perry W Grigsby
Radiation Oncology (London, England)|May 26, 2006
Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literatureJon C Anders, Perry W Grigsby, Anurag K Singh
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancerFei Yang, Maria A Thomas, Farrokh Dehdashti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2009
The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovariesJulie K Schwarz, Perry W Grigsby, Farrokh Dehdashti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancerTom R Miller, Edward Pinkus, Farrokh Dehdashti, et al.
Cancer|September 6, 2007
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survivalElizabeth A Kidd, Barry A Siegel, Farrokh Dehdashti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Posttherapy surveillance monitoring of cervical cancer by FDG-PETPerry W Grigsby, Barry A Siegel, Farrokh Dehdashti, et al.
Pageof 19

Showing results (31-40 of 190) with videos related to

Sort By:
Pageof 19
Gynecologic Oncology|November 7, 2009
A new method of anatomically conformal vaginal cuff HDR brachytherapyDouglas A Miller, Susan Richardson, Perry W Grigsby
Cancer|November 23, 2005
FDG-PET in carcinoma of the uterine cervix with endometrial extensionAndrew J Hope, Paban Saha, Perry W Grigsby
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
Tumor volume discrepancies between FDG-PET and MRI for cervical cancerDaniel J Ma, Jian-Ming Zhu, Perry W Grigsby
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Change in T2-fat saturation MRI correlates with outcome in cervical cancer patientsDaniel J Ma, Jian-Ming Zhu, Perry W Grigsby
Radiation Oncology (London, England)|May 26, 2006
Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literatureJon C Anders, Perry W Grigsby, Anurag K Singh
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancerFei Yang, Maria A Thomas, Farrokh Dehdashti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2009
The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovariesJulie K Schwarz, Perry W Grigsby, Farrokh Dehdashti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancerTom R Miller, Edward Pinkus, Farrokh Dehdashti, et al.
Cancer|September 6, 2007
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survivalElizabeth A Kidd, Barry A Siegel, Farrokh Dehdashti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Posttherapy surveillance monitoring of cervical cancer by FDG-PETPerry W Grigsby, Barry A Siegel, Farrokh Dehdashti, et al.
Pageof 19